Can SLE go into remission?

Yes -- SLE can achieve complete clinical remission in a proportion of patients. Early intensive treatment increases the chance of achieving remission. Lifelong monitoring is required as quiescent disease can flare unexpectedly.

Why am I asked to provide a urine sample at every appointment?

Lupus nephritis can develop without any symptoms and the earliest detectable sign is protein or blood in the urine. Testing at every appointment detects lupus nephritis before kidney function is impaired.

Can I get pregnant with SLE?

Yes -- pregnancy in SLE requires careful planning with at least 6 months of remission before conception on hydroxychloroquine which is safe in pregnancy. Antiphospholipid antibody testing before pregnancy guides anticoagulation requirements.

Why must I avoid sun exposure with SLE?

UV radiation directly activates the immune pathway driving SLE inflammation causing both skin rashes and systemic flares. 70% of SLE patients have photosensitivity. SPF50+ sunscreen applied daily is essential disease management.

What is antiphospholipid syndrome?

Antiphospholipid syndrome occurs in 30 to 40% of SLE patients -- antibodies cause arterial and venous thrombosis and pregnancy loss. Confirmed APS requires lifelong anticoagulation.

Systemic Lupus Erythematosus Management

SLE Management provides specialist rheumatology care using hydroxychloroquine, immunosuppressants, and biologics to control disease activity, prevent organ damage, minimise flares, and support patients through this complex multisystem autoimmune condition.

Book Appointment Call Now

Overview

Key Benefits

Discover the advantages of choosing our systemic lupus erythematosus management services.

Hydroxychloroquine reduces SLE flare frequency by 50% and improves long-term survival

Early detection of lupus nephritis enables treatment before irreversible renal scarring

Belimumab reduces severe flare frequency by 30 to 40% in seropositive active SLE

Aggressive cardiovascular risk management reduces the leading cause of mortality in SLE

Sustained remission allows cautious DMARD dose reduction in stable patients

Clinical Features

The technology, techniques and clinical approach behind our systemic lupus erythematosus management.

SLEDAI-2K score calculated at every appointment providing the objective disease activity measure

Fresh urine sample tested at every clinic -- lupus nephritis can develop asymptomatically

Hydroxychloroquine blood level testing confirms therapeutic dosing and adherence

Mycophenolate mofetil is the preferred maintenance therapy for lupus nephritis

SPF50+ sunscreen every day is as important as medication for SLE control

Preparation Instructions

Take hydroxychloroquine every day without fail -- it is the cornerstone of SLE management. Apply SPF50 sunscreen and wear UV-protective clothing consistently as UV exposure triggers lupus flares. Attend annual ophthalmology screening if on hydroxychloroquine for more than 5 years. Contact your rheumatology team promptly for any fever, worsening rash, new joint swelling, chest pain, or blood in the urine.

The Procedure

Step-by-step guide to what you can expect during your systemic lupus erythematosus management procedure.

SLEDAI Disease Activity Scoring
The SLE Disease Activity Index (SLEDAI-2K) is calculated at every appointment scoring clinical and laboratory manifestations across 24 domains -- the objective disease activity measure driving treatment escalation decisions.
Urinalysis and Renal Function Review
A fresh urine sample is dipstick tested at every appointment for protein and blood -- the earliest detectable manifestation of lupus nephritis. Protein-creatinine ratio and GFR are checked if dipstick is positive.
Hydroxychloroquine Optimisation
Hydroxychloroquine is the cornerstone therapy for all SLE patients. Blood level testing confirms adequate dosing (target 750 to 1000 ng/mL) -- sub-therapeutic levels from poor adherence are the most common reason for inadequate disease control.
Immunosuppressant Review
Azathioprine mycophenolate or methotrexate doses are reviewed against disease activity and side effects. For active lupus nephritis Class III or IV high-dose mycophenolate plus belimumab provides best renal protection.
Photosensitivity and Sun Protection
High factor (SPF50+) broad-spectrum sunscreen is essential for all sun-exposed skin -- UV exposure directly triggers cutaneous and systemic flares. Practical daily sun protection strategies are discussed at every appointment.
Cardiovascular Risk Management
SLE increases cardiovascular risk 5 to 10-fold. Aggressive management of all cardiovascular risk factors -- blood pressure below 130/80 LDL below 2.6 smoking cessation and exercise -- is as important as controlling disease activity.

What to Expect

Your rheumatologist calculates SLEDAI score, reviews blood results, dipsticks urine for protein and blood, and examines all affected organ systems. Treatment is adjusted based on disease activity and organ involvement. Hydroxychloroquine blood levels may be checked to confirm adequate dosing. Cardiovascular risk factor management is reviewed alongside immunosuppressive therapy.

Systemic Lupus Erythematosus Management

Overview

Key Benefits

Clinical Features

Preparation Instructions

The Procedure

SLEDAI Disease Activity Scoring

Urinalysis and Renal Function Review

Hydroxychloroquine Optimisation

Immunosuppressant Review

Photosensitivity and Sun Protection

Cardiovascular Risk Management

What to Expect

Frequently Asked Questions

Related Services

Rheumatoid Arthritis Management

Osteoporosis Assessment and Treatment

Gout and Crystal Arthropathy

Ready to Get Started?